Dr Adam Davenport appointed as CSO to strengthen leadership in integrated drug discovery
We are pleased to announce the appointment of Dr Adam Davenport as Chief Scientific Officer to spearhead our integrated drug discovery offering for biotech and pharmaceutical partners.